{"filing":{"accession_number":"0001493152-26-047888","cik":"0001838716","ticker":"GNTA","company_name":"Genenta Science S.p.A.","form":"6-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1838716/000149315226047888/form6-k.htm"},"events":[{"id":36727,"run_id":33861,"accession_number":"0001493152-26-047888","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"Genenta Science received a Nasdaq notification on October 16, 2026, that it failed to maintain the minimum bid price of $1.00 per share for 30 consecutive business days. The company has been given 180 calendar days (until April 14, 2027) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, as it directly threatens the company's continued listing on Nasdaq Capital Market.","company_name":"Genenta Science S.p.A.","ticker":"GNTA","filing_date":"2026-10-21","form":"6-K","submitted_at":null,"items":[{"id":41235,"accession_number":"0001493152-26-047888","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"Genenta Science received a Nasdaq notification on October 16, 2026, that it failed to maintain the minimum bid price of $1.00 per share for 30 consecutive business days. The company has been given 180 calendar days (until April 14, 2027) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, as it directly threatens the company's continued listing on Nasdaq Capital Market.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T20:21:15.321296+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41235,"accession_number":"0001493152-26-047888","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"Genenta Science received a Nasdaq notification on October 16, 2026, that it failed to maintain the minimum bid price of $1.00 per share for 30 consecutive business days. The company has been given 180 calendar days (until April 14, 2027) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, as it directly threatens the company's continued listing on Nasdaq Capital Market.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T20:21:15.321296+00:00","company_name":"Genenta Science S.p.A.","ticker":"GNTA","filing_date":"2026-10-21"}]}